Telbivudine

Telbivudine (Epavudine), an orally active thymidine nucleoside analog, is a potent antiviral inhibitor of hepatitis B virus (HBV) replication[1].

Product Specifications

CAS Number

[3424-98-4]

Product Name Alternative

Epavudine; L-Thymidine; NV 02B

UNSPSC

12352005

Hazard Statement

H302

Target

HBV

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-anti-virus

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/telbivudine.html

Purity

99.92

Solubility

DMSO : 50 mg/mL (ultrasonic) |H2O : 33.33 mg/mL (ultrasonic)

Smiles

O=C(N1)N([C@@H]2C[C@@H](O)[C@H](CO)O2)C=C(C)C1=O

Molecular Formula

C10H14N2O5

Molecular Weight

242.23

Precautions

H302

References & Citations

[1]Kim JW, et al. Telbivudine: a novel nucleoside analog for chronic hepatitis B. Ann Pharmacother. 2006;40 (3) :472-478.|[2]Zobel T, et al. Telbivudine Reduces Parvovirus B19-Induced Apoptosis in Circulating Angiogenic Cells. Viruses. 2019;11 (3) :227. Published 2019 Mar 6.